PNC Financial Services Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05K | Hold |
100
| – | – | ﹤0.01% | 4399 |
|
|
2025
Q1 | $2.05K | Hold |
100
| – | – | ﹤0.01% | 4336 |
|
|
2024
Q4 | $2.26K | Hold |
100
| – | – | ﹤0.01% | 4252 |
|
|
2024
Q3 | $2.46K | Hold |
100
| – | – | ﹤0.01% | 4241 |
|
|
2024
Q2 | $2.31K | Hold |
100
| – | – | ﹤0.01% | 4221 |
|
|
2024
Q1 | $2.41K | Hold |
100
| – | – | ﹤0.01% | 4156 |
|
|
2023
Q4 | $2.3K | Hold |
100
| – | – | ﹤0.01% | 4166 |
|
|
2023
Q3 | $2.04K | Sell |
100
-602
| -86% | -$12.3K | ﹤0.01% | 4241 |
|
|
2023
Q2 | $16.4K | Hold |
702
| – | – | ﹤0.01% | 3638 |
|
|
2023
Q1 | $16.3K | Sell |
702
-155
| -18% | -$3.61K | ﹤0.01% | 3588 |
|
|
2022
Q4 | $21.6K | Hold |
857
| – | – | ﹤0.01% | 3429 |
|
|
2022
Q3 | $23K | Hold |
857
| – | – | ﹤0.01% | 3380 |
|
|
2022
Q2 | $25K | Sell |
857
-800
| -48% | -$23.3K | ﹤0.01% | 3378 |
|
|
2022
Q1 | $57K | Buy |
1,657
+427
| +35% | +$14.7K | ﹤0.01% | 3031 |
|
|
2021
Q4 | $54K | Hold |
1,230
| – | – | ﹤0.01% | 3066 |
|
|
2021
Q3 | $62K | Buy |
1,230
+550
| +81% | +$27.7K | ﹤0.01% | 2935 |
|
|
2021
Q2 | $35K | Buy |
680
+190
| +39% | +$9.78K | ﹤0.01% | 3241 |
|
|
2021
Q1 | $22K | Buy |
+490
| New | +$22K | ﹤0.01% | 3368 |
|